# Primary Organoid Models and Combined Nucleic Acids Therapeutics for Anti-HPV Treatments

> **NCT04278326** · NA · TERMINATED · sponsor: **Centre Hospitalier Régional d'Orléans** · enrollment: 14 (actual)

## Conditions studied

- HPV Infection
- Vaginal Cancer
- Cervical Dysplasia
- Cervical Cancer

## Interventions

- **PROCEDURE:** Vaginal Biopsy

## Key facts

- **NCT ID:** NCT04278326
- **Lead sponsor:** Centre Hospitalier Régional d'Orléans
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-12-21
- **Primary completion:** 2021-12-21
- **Final completion:** 2021-12-21
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** the partner laboratory encountered various difficulties (COVID, relocation of the laboratory, personnel problems), which prevented the organoid model from being built
- **Last updated:** 2025-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04278326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04278326, "Primary Organoid Models and Combined Nucleic Acids Therapeutics for Anti-HPV Treatments". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04278326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*